More Sihuan Pharmaceutical Holdings Group Ltd. news
Sihuan Pharmaceutical Holdings Group Ltd.HKEX: 460

Next Day Disclosure Return

Nov 19, 2026 at 6:04 AM EST · Issued by Sihuan Pharmaceutical Holdings Group Ltd. via HKEXnews

Filed with HKEX · Stock code 460 · Nov 19, 2026 at 6:04 AM EST · 5 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-return-3117

Sihuan Pharmaceutical Holdings Group Ltd. on 6ix

Earlier from Sihuan Pharmaceutical

  • Voluntary announcement - new indication of xuanzhu biopharm's Bireociclib included in the 2026 NRDLNov 16
  • Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026Nov 2
  • Voluntary announcement- phase III clinical study data of xuanzhu biopharm's Anaprazole Sodium for reflux esophagitis presented at UEG Week 2026Oct 21
  • Voluntary announcement - polycaprolactone microsphere facial filler for Injection and hyaluronic acid sodium composite solution for Injection independently developed by meiyan space, a subsidiary of Sihuan Pharmaceutical, approved for market launch in hong kongOct 20
  • Voluntary announcement-Sihuan Pharmaceutical completed a strategic investment in canton biologics to enhance the layout of the entire industrial chain of regenerative medical aestheticsOct 8

Later from Sihuan Pharmaceutical

  • Voluntary announcement share repurchaseNov 19
All Sihuan Pharmaceutical news releases↗

Follow Sihuan Pharmaceutical into a list and get an email when it puts out news.

Follow Sihuan Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer